2nd Quarter - Report

THE MCMANUS GROUP for ALLERGAN INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Extension of the research and development tax credit. H.R. 2138, "Investment in America Act of 2007." H.R. 6049, "Renewable Energy and Job Creation Act of 2008," Sec. 221

LobbyistCovered position, as disclosed
JOHN MCMANUS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2138 (110th), H.R. 6049 (110th)

Medicare/Medicaid MMM

Clarification of the scope of Medicaid rebates for physician-administered drugs.

LobbyistCovered position, as disclosed
JOHN MCMANUS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.